Skip to main content
. 2018 Sep 1;25(9):846–984. doi: 10.5551/jat.GL2017

Table 2. Lipid Management Targets for Patients with Different Risk Category.

graphic file with name jat-25-846-g019.jpg
*

For patients who are also suffering from high-risk conditions, such as FH, ACS, and diabetes complicated by other high-risk conditions shown in Table 3b, stricter LDL-C control should be considered, with a level of < 70 mg/dL as the target.

  • Although non-drug therapy is used as a standard means for achieving the management target in primary prevention, drug therapy should be considered for patients with low risk if the LDL-C level is ≥ 180 mg/dL. The possibility of FH should also be considered (refer to Chapter 5).
  • Achieving the LDL-C management target should be the first goal, and reaching the non-HDL-C management target should be the next goal after the first goal has been achieved. Managing the TG and HDL-C levels is important during this process.
  • These values are challenging goals by utmost effort; a 20%–30% reduction in LDL-C levels for primary prevention (low or moderate risk) and a decrease of ≥ 50% for secondary prevention are also possible targets.
  • For elderly patients (aged ≥ 75 years), refer to Chapter 7.